Outlook Therapeutics Inc (OTLK)
8.90
-0.02
(-0.22%)
USD |
NASDAQ |
May 01, 09:56
Outlook Therapeutics Max Drawdown (5Y): 98.82% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 98.82% |
March 31, 2024 | 98.82% |
February 29, 2024 | 98.82% |
January 31, 2024 | 98.82% |
December 31, 2023 | 98.82% |
November 30, 2023 | 98.82% |
October 31, 2023 | 98.82% |
September 30, 2023 | 98.82% |
August 31, 2023 | 98.82% |
July 31, 2023 | 98.82% |
June 30, 2023 | 98.82% |
May 31, 2023 | 98.82% |
April 30, 2023 | 98.82% |
March 31, 2023 | 98.82% |
February 28, 2023 | 98.82% |
January 31, 2023 | 98.82% |
December 31, 2022 | 98.82% |
November 30, 2022 | 98.82% |
October 31, 2022 | 98.82% |
September 30, 2022 | 98.82% |
August 31, 2022 | 98.82% |
July 31, 2022 | 98.82% |
June 30, 2022 | 98.82% |
May 31, 2022 | 98.82% |
April 30, 2022 | 98.82% |
Date | Value |
---|---|
March 31, 2022 | 98.82% |
February 28, 2022 | 98.82% |
January 31, 2022 | 98.82% |
December 31, 2021 | 98.82% |
November 30, 2021 | 98.82% |
October 31, 2021 | 98.82% |
September 30, 2021 | 98.82% |
August 31, 2021 | 98.82% |
July 31, 2021 | 98.82% |
June 30, 2021 | 98.82% |
May 31, 2021 | 98.82% |
April 30, 2021 | 98.82% |
March 31, 2021 | 98.82% |
February 28, 2021 | 98.82% |
January 31, 2021 | 98.82% |
December 31, 2020 | 98.82% |
November 30, 2020 | 98.82% |
October 31, 2020 | 98.82% |
September 30, 2020 | 98.82% |
August 31, 2020 | 98.82% |
July 31, 2020 | 98.82% |
June 30, 2020 | 98.82% |
May 31, 2020 | 98.82% |
April 30, 2020 | 98.82% |
March 31, 2020 | 98.82% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.90%
Minimum
May 2019
98.82%
Maximum
Mar 2020
98.71%
Average
98.82%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Cutera Inc | 98.09% |
Actinium Pharmaceuticals Inc | 97.29% |
GT Biopharma Inc | 100.00% |
Karyopharm Therapeutics Inc | 97.56% |
Marinus Pharmaceuticals Inc | 94.98% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -23.96 |
Beta (5Y) | 0.2828 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 110.7% |
Historical Sharpe Ratio (5Y) | -0.188 |
Historical Sortino (5Y) | -0.3331 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.01% |